ritonavir has been researched along with ebselen* in 1 studies
1 other study(ies) available for ritonavir and ebselen
Article | Year |
---|---|
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
The SARS-CoV-2 virus is causing COVID-19 resulting in an ongoing pandemic with serious health, social, and economic implications. Much research is focused in repurposing or identifying new small molecules which may interact with viral or host-cell molecular targets. An important SARS-CoV-2 target is the main protease (M Topics: Amides; Antiviral Agents; Azoles; Coronavirus 3C Proteases; Coronavirus Protease Inhibitors; Humans; Isoindoles; Ligands; Lopinavir; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organoselenium Compounds; Protein Multimerization; Ritonavir; SARS-CoV-2; Small Molecule Libraries | 2020 |